Form C: Issuer Information

Issuer Information

Name of Issuer:

Mahzi Therapeutics, Inc.

Legal Status of Issuer:

Form:

Corporation

Jurisdiction of Incorporation/Organization:

DELAWARE

Date of Incorporation/Organization:

06-30-2020

Physical Address of Issuer:

Address 1:

470 Noor Avenue

Address 2:

Suite B, #1036

City:

South San Francisco

State/Country:

CALIFORNIA

Mailing Zip/Postal Code:

94080

Website of Issuer:

https://www.mahzi.com

Is there a Co-issuer?

Yes

If yes, specify the following for the Co-issuer:

EDGAR Filer?

CIK of Co-issuer:

Name of Co-issuer:

Mahzi Therapeutics, Inc I, a series of Wefunder SPV, LLC

Legal Status of Co-issuer:

Form:

Limited Liability Company

Jurisdiction of Incorporation/Organization:

DELAWARE

Date of Incorporation/Organization:

06-16-2026

Physical Address of Co-issuer:

Address 1:

1887 Whitney Mesa Dr

Address 2:

NUM 8885

City:

Henderson

State/Country:

NEVADA

Mailing Zip/Postal Code:

89014

Website of Co-issuer:

https://wefunder.com/

Intermediary through which the Offering will be Conducted:

CIK:

0001670254

Company Name:

Wefunder Portal LLC

Commission File Number:

007-00033

CRD Number:

283503

Form C: Offering Information

Offering Information

Amount of compensation to be paid to the intermediary, whether as a dollar amount or a percentage of the offering amount, or a good faith estimate if the exact amount is not available at the time of the filing, for conducting the offering, including the amount of referral and any other fees associated with the offering:

5.0% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.

Any other financial interest in the issuer held by the intermediary, or any arrangement for the intermediary to acquire such an interest:

Type of Security Offered:

Preferred Stock

Specify:

Target Number of Securities to be Offered:

14410

Price:

3.47000

Price (or Method for Determining Price):

Dividing pre-money valuation $87,900,000.00 by number of shares outstanding on fully diluted basis.

Target Offering Amount:

50000.00

Maximum Offering Amount (if different from Target Offering Amount):

1200000.00

Oversubscriptions Accepted:

Yes

If yes, disclose how oversubscriptions will be allocated:

Other

Provide a description:

As determined by the issuer

Deadline to reach the Target Offering Amount:

12-31-2026

NOTE: If the sum of the investment commitments does not equal or exceed the target offering amount at the offering deadline, no securities will be sold in the offering, investment commitments will be cancelled and committed funds will be returned.

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:

Total Assets Most Recent Fiscal Year-end:

11638540.00

Total Assets Prior Fiscal Year-end:

18971450.00

Cash and Cash Equivalents Most Recent Fiscal Year-end:

10695753.00

Cash and Cash Equivalents Prior Fiscal Year-end:

10260277.00

Accounts Receivable Most Recent Fiscal Year-end:

0.00

Accounts Receivable Prior Fiscal Year-end:

0.00

Short-term Debt Most Recent Fiscal Year-end:

6760112.00

Short-term Debt Prior Fiscal Year-end:

2058254.00

Long-term Debt Most Recent Fiscal Year-end:

1137377.00

Long-term Debt Prior Fiscal Year-end:

0.00

Revenue/Sales Most Recent Fiscal Year-end:

0.00

Revenue/Sales Prior Fiscal Year-end:

0.00

Cost of Goods Sold Most Recent Fiscal Year-end:

0.00

Cost of Goods Sold Prior Fiscal Year-end:

0.00

Taxes Paid Most Recent Fiscal Year-end:

0.00

Taxes Paid Prior Fiscal Year-end:

0.00

Net Income Most Recent Fiscal Year-end:

-18656306.00

Net Income Prior Fiscal Year-end:

-11885773.00